
Keywords: acute coronary syndrome; anti-inflammatory; drug targets; ACS; acute coronary syndromes; CABG; coronary artery bypass graft; CAD; coronary artery disease; HDL-C; high-density lipoprotein cholesterol; hsCRP; high-sensitivity C-reactive protein; IL; interle